An asset can be scientifically excellent.
But one question remains: excellent for whom?
For R&D, excellence is proven by mechanisms of action, in vitro studies and in vivo clinical data.
This is the essential foundation, the sine qua non condition.
However, for a brand, the real issue lies elsewhere.
The question becomes: "What can I tell my clients?"
And above all, is the difference really perceived? At Syres, we do not see scientific evidence and consumer testing as opposing forces.
On the contrary, we are working on their continuity.
Take the example of a deodorant: we use a half-body protocol (active vs placebo) with an "expert sniff" assessment and a self-assessment at T0, T12h and T24h.
We are not just measuring a technical gap; we are measuring the perceived gap.
The same logic applies to an anti-blemish treatment: on two homogeneous groups for 56 days.
Statistical analysis confirms the difference.
A manufacturer who only provides technical data remains within a purely scientific discourse.
To move to the next level and become a strategic partner for brands, it needs to offer more.
Providing an asset accompanied by: A comparative study of the active vs. placebo, Statistically significant results in perception, Directly usable customer verbatim comments, ...is to offer a true "turnkey" marketing deployment package.
"Instrumental performance reassures R&D.
Consumer validation reassures the brand.
When the two converge, the asset becomes a commercial weapon." By reconciling these two worlds, you are no longer just selling a molecule, you are selling guaranteed commercial success.
There is still time to increase the value of your asset.
We can implement short-term kinetic studies to arrive at the trade show with impactful perception evidence. Contact us today to discuss your consumer research.
